US Broker Ratings

Kymera Therapeutics, Inc. (KYMR) Growth Potential: A 21% Upside with Strong Buy Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to drug development and a compelling..

IDEAYA Biosciences, Inc. (IDYA)

⚠️ No article content returned.

..

Indivior Pharmaceuticals (INDV) Stock Analysis: Unveiling a 41.78% Potential Upside

Investors eyeing opportunities in the healthcare sector might find Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) an intriguing prospect. This U.S.-based drug manufacturer specializes in treatments for opioid..

Astrana Health Inc. (ASTH) Stock Analysis: A Promising 38.78% Upside in the Healthcare Sector

As investors navigate the intricate landscape of the healthcare sector, Astrana Health Inc. (NASDAQ: ASTH) emerges as a compelling proposition. With a market capitalization of $1.85..

AdaptHealth Corp. (AHCO) Stock Analysis: Investor Outlook with Nearly 50% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO) presents an intriguing opportunity for investors with its significant potential upside, despite facing some challenging financial metrics. As a key player in..

Alvotech (ALVO) Stock Analysis: Potential Upside of 55.84% Draws Investor Attention

Alvotech (NASDAQ: ALVO), a Luxembourg-based biopharmaceutical company specializing in biosimilar medicines, is capturing investor interest with a compelling potential upside of 55.84%, according to recent analyst..

Belite Bio, Inc (BLTE) Stock Analysis: A 59.67% Upside with Strong Buy Ratings

Belite Bio, Inc (BLTE), a promising player in the biotechnology sector, has been catching the attention of investors with its innovative approach to addressing unmet medical..

Warby Parker Inc. (WRBY) Stock Analysis: Unveiling a 22.63% Upside Potential in the Eyewear Market

Warby Parker Inc. (NYSE: WRBY) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Addus HomeCare (ADUS) Stock Analysis: Unlocking a 10.65% Potential Upside in the Growing Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS) stands as a compelling opportunity for investors looking to capitalize on the burgeoning healthcare sector. With a market capitalization of $2.26..

BGM Group Ltd. (BGM): Investor Outlook on a High-Growth Revenue Player in the Healthcare Sector

BGM Group Ltd. (BGM), an intriguing player in the healthcare sector, is making waves with its remarkable revenue growth rate of 69.80%. As a pharmaceutical and..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 55.99% Upside Potential

Alignment Healthcare, Inc. (NASDAQ: ALHC) has caught the attention of investors with its unique focus on providing tailored healthcare experiences for seniors through Medicare Advantage plans...

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A Look at Its 9.42% Potential Upside

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is carving out a significant niche in the global biopharmaceutical industry. With a robust portfolio ranging from generics to specialty branded..

Bausch Health Companies Inc. (BHC) Stock Analysis: Discover the 18% Upside Potential

Bausch Health Companies Inc. (NYSE: BHC) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in..

PROCEPT BioRobotics Corporation (PRCT) Investor Outlook: Navigating a 12.20% Potential Upside Amidst Innovative Growth

For investors eyeing the healthcare sector, particularly within the realm of medical devices, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a compelling case for consideration. The company,..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unveiling a 119% Upside Potential Amid Innovative Gene Editing Advances

Beam Therapeutics Inc. (NASDAQ: BEAM), a Massachusetts-based biotechnology firm, is at the forefront of precision genetic medicine development, targeting serious diseases through cutting-edge gene editing technologies...

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 102% Potential Upside in Biotechnology

In the highly competitive biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) is capturing investor attention with its cutting-edge immunotherapy platforms and a staggering 102% potential upside..

Xenon Pharmaceuticals (XENE) Stock Analysis: Neuroscience Innovations with a Potential 101% Upside

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a leader in the biopharmaceutical sector with a focus on neuroscience, has been capturing investor attention with its innovative pipeline and..

UFP Technologies, Inc. (UFPT) Stock Analysis: Uncovering a 21.88% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a prominent player in the healthcare sector with a specialization in medical devices, is capturing investor attention with its compelling growth..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: Analyzing the 68.87% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) stands at a pivotal juncture for investors interested in the biotechnology sector. With a market capitalization of $5.08 billion, the..

Envista Holdings Corporation (NVST) Stock Analysis: Exploring a 21% Potential Upside for Investors

Envista Holdings Corporation (NYSE: NVST) is a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds